Brief: Hemcheck Sweden Q2 Pretax Loss Widens To SEK 3.2 Million

Bio Vitos Pharma AB

31/08/2020 07:33

Aug 31 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * Q2 OPERATING REVENUE SEK 53,975 VERSUS SEK 0 YEAR AGO
    * Q2 PRETAX LOSS SEK 3.2 MILLION VERSUS LOSS SEK 1.7 MILLION
YEAR
AGO

Source text for Eikon:  ID:nWkrbQZkcM 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))